Mirae Asset Global ETFs Holdings
NVCR icon

Mirae Asset Global ETFs Holdings’s NovoCure NVCR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
93,815
-493
-0.5% -$7.46K ﹤0.01% 1443
2026
Q1 		$1.03M Sell
94,308
-11,104
-11% -$139K ﹤0.01% 1511
2025
Q4 		$1.36M Sell
105,412
-2,383
-2% -$30.6K ﹤0.01% 1348
2025
Q3 		$1.39M Sell
107,795
-12
-0% -$160 ﹤0.01% 1308
2025
Q2 		$1.92M Buy
107,807
+32,815
+44% +$572K ﹤0.01% 1115
2025
Q1 		$1.34M Buy
74,992
+2,502
+3% +$56.8K ﹤0.01% 1350
2024
Q4 		$2.16M Buy
72,490
+1,978
+3% +$41.9K ﹤0.01% 1087
2024
Q3 		$1.1M Buy
70,512
+58,402
+482% +$1.06M ﹤0.01% 1487
2024
Q2 		$207K Buy
+12,110
New +$213K ﹤0.01% 2230

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NVCR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its NovoCure (NVCR) stake by 0.52% in Q2 2026, selling an estimated $7.46K and leaving 93,815 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

Mirae Asset Global ETFs Holdings first reported a position in NVCR in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.16M in Q4 2024. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 93,815 shares of NovoCure worth $1.42M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 493 NovoCure shares in Q2 2026, an estimated $7.46K.
  • NovoCure made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1443 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in NovoCure in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's NovoCure position peaked at $2.16M in Q4 2024.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.